Convalescent plasma is an experimental procedure for COVID-19 patients. As per the guidelines, hospitals and institutions planning to provide this modality of treatment should do so in a clinical trial with protocols which are cleared by the Institutional Ethics Committee.from Industry-Economic Times
Read The Rest:economictimes...
